E Briët

A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy

F.R. Rosendaal, Suzanne C. Cannegieter, F.J.M. van der Meer et al. · Thrombosis and Haemostasis · 1993 · 2K citations

Oral Anticoagulant Therapy, Pharmacotherapy, Optimal Achieved Intensity +19

Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study

Ted Koster, FR Rosendaal, Hans de Ronde et al. · The Lancet · 1993 · 1.3K citations

Thrombopoiesis, Thrombosis, Venous Thrombosis +9

Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis

Ted Koster, Jan P. Vandenbroucke, F. R. Rosendaal et al. · The Lancet · 1995 · 1.1K citations

Thrombosis, Venous Thrombosis, Von Willebrand Factor +10

Optimal Oral Anticoagulant Therapy in Patients with Mechanical Heart Valves

Suzanne C. Cannegieter, Frits R. Rosendaal, Axel R. Wintzen et al. · New England Journal of Medicine · 1995 · 910 citations · Full text

Increased fetal loss in women with heritable thrombophilia

F E Preston, FR Rosendaal, I.D. Walker et al. · The Lancet · 1996 · 676 citations

Infertility, Hematology, Reproductive Health +9